Junguo Cao

Publication Activity (10 Years)

Years Active: 2018-2022
Publications (10 Years): 5

Top Topics

Drug Administration

Tyrosine Kinase

Binding Protein

Top Venues

Stem cells international

Clinical cancer research : an official journal of the American Association for Cancer Research

The Journal of clinical endocrinology and metabolism

This page only lists publications with an associated author ORCID identifier.

Publications

Junguo Cao, Weijia Yan, Guihong Li, Zhixin Zhan, Xinyu Hong, Hong Yan
Incidence and survival of benign, borderline, and malignant meningioma patients in the United States from 2004 to 2018. International journal of cancer 151 (11) (2022)
Gerhard Jungwirth, Tao Yu, Fang Liu, Junguo Cao, Montadar Alaa Eddine, Mahmoud Moustafa, Amir Abdollahi, Rolf Warta, Andreas W Unterberg, Christel Herold-Mende
Pharmacological Landscape of FDA-approved Anticancer Drugs Reveals Sensitivities to Ixabepilone, Romidepsin, Omacetaxine, and Carfilzomib in Aggressive Meningiomas. Clinical cancer research : an official journal of the American Association for Cancer Research (2022)
Junguo Cao, Weijia Yan, Xiujian Ma, Qingchun Mu, Pengcheng Zhang
Insulin-like Growth Factor 2 mRNA-Binding Protein 2-a Potential Link Between Type 2 Diabetes Mellitus and Cancer. The Journal of clinical endocrinology and metabolism 106 (10) (2021)
Tao Yu, Junguo Cao, Montadar Alaa Eddine, Mahmoud Moustafa, Andreas Mock, Cihan Erkut, Amir Abdollahi, Rolf Warta, Andreas Unterberg, Christel Herold-Mende, Gerhard Jungwirth
Receptor-Tyrosine Kinase Inhibitor Ponatinib Inhibits Meningioma Growth In Vitro and In Vivo. Cancers 13 (23) (2021)
Junguo Cao, Qingchun Mu, Qingchun Mu
The Roles of Insulin-Like Growth Factor 2 mRNA-Binding Protein 2 in Cancer and Cancer Stem Cells. Stem cells international 2018 (2018)